Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Medical Countermeasures Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic FeverGlobal Biodefense StaffJune 5, 2025
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control Medical Countermeasures June 21, 2022 …
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs Industry News June 20, 2022 …
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine Medical Countermeasures May 30, 2022 …
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors Industry News May 26, 2022 …
New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs Medical Countermeasures April 10, 2022 …
Troubling Trends in Physician Vaccine Confidence in the United States Medical Countermeasures April 5, 2022 …
Northwestern University Researchers Develop Nanoparticle Vaccine Platform Medical Countermeasures March 22, 2022 …
CounterACT: U.S. Funding Early Stage Drug Discovery of Countermeasures Against Chemical Threats CBRNE March 21, 2022 …
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines Medical Countermeasures March 19, 2022 …
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus Medical Countermeasures March 10, 2022 …
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate Industry News March 3, 2022 …
Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis CBRNE February 27, 2022 …
Novel Antibiotic Shows Success in Treatment of Plague and Melioidosis Antimicrobial Resistance February 17, 2022 …
